Početna › Rak dojke › Ohio › Cincinnati
Kliničke studije za Rak dojke u gradu Cincinnati, OH
25 studija za Rak dojke traži sudionike na lokacijama u gradu Cincinnati i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- i još 3
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
U tijeku regrutacijaFaza 3
- TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0020), Cincinnati
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
U tijeku regrutacijaFaza 3
- Good Samaritan Hospital-TriHealth Cancer institute ( Site 0027), Cincinnati
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
U tijeku regrutacijaFaza 3
- Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0053), Edgewood · 8 mi udaljenosti
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
U tijeku regrutacijaFaza 3
- University of Cincinnati Medical Center, Cincinnati
- University of Cincinnati Medical Center - West Chester Hospital, West Chester · 15 mi udaljenosti
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
U tijeku regrutacijaFaza 3
- Research Site, Cincinnati
- Research Site, Cincinnati
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
U tijeku regrutacijaFaza 3
- Clinical Trial Site, Cincinnati
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
U tijeku regrutacijaFaza 3
- Saint Elizabeth Medical Center Edgewood, Edgewood · 8 mi udaljenosti
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
U tijeku regrutacijaFaza 3
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15 mi udaljenosti
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
U tijeku regrutacijaFaza 3
- Research Site, Edgewood · 8 mi udaljenosti
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
U tijeku regrutacijaFaza 1/2
- University of Cincinnati Medical Center, Cincinnati
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
U tijeku regrutacijaOpažajna studija
- University of Cincinnati Medical Center, Cincinnati
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
U tijeku regrutacijaFaza 3
- The Christ Hospital, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- i još 2
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
U tijeku regrutacijaFaza 1
- St. Elizabeth Healthcare, Edgewood · 8 mi udaljenosti
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
U tijeku regrutacijaFaza 3
- Oncology Hematology Care, Cincinnati
E-Mindfulness Approaches for Living After Breast Cancer
U tijeku regrutacijaFaza 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi udaljenosti
Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)
U tijeku regrutacija
- University of Cincinnati, Cincinnati
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
U tijeku regrutacijaFaza 2
- The Christ Hospital Cancer Center, Cincinnati
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
U tijeku regrutacijaFaza 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi udaljenosti
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
U tijeku regrutacijaFaza 1/2
- Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center, Cincinnati
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
U tijeku regrutacijaOpažajna studija
- St. Elizabeth Edgewood Hospital, Edgewood · 8 mi udaljenosti
Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks
U tijeku regrutacijaFaza 4
- University of Cincinnati Medical Center, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
U tijeku regrutacijaOpažajna studija
- Massive Bio SYNERGY-AI site, Cincinnati
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
U tijeku regrutacijaFaza 3
- The Christ Hospital, Cincinnati
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi udaljenosti
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
U tijeku regrutacijaOpažajna studija
- TriHealth Cancer Institutes, Cincinnati
- Oncology Hematology Care, Cincinnati
Studije za Rak dojke u drugim gradovima
- New York City, NY134 studija
- Houston, TX126 studija
- Boston, MA111 studija
- Nashville, TN80 studija
- Los Angeles, CA72 studija
- Edison, NJ68 studija
- St. Louis, MO64 studija
- Durham, NC63 studija
- Queens, NY63 studija
- Chicago, IL58 studija
- Philadelphia, PA56 studija
- Dallas, TX55 studija
Ostale studije u gradu Cincinnati
- Nemikrocelularni karcinom pluća35 studija
- Rak (sve vrste)27 studija
- Srčano zatajenje24 studija
- Kolorektalni rak21 studija
- Akutna mijeloična leukemija20 studija
- Metastatski karcinom20 studija
- Rak jajnika19 studija
- Rak pluća19 studija
- Debljina19 studija
- Rak prostate18 studija
- Multipli mijelom17 studija
- Melanom17 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.